News
Moderna’s COVID-19 vaccine shows positive results in phase 1 clinical trials
“With these positive interim Phase 1 data and the positive data in the mouse challenge model, the Moderna team continues to focus on moving as fast as safely possible to start our pivotal Phase 3 study in July and, if successful, file a BLA,” said Dr Stéphane Bancel, CEO, Moderna.
Biocon Biologics gets EU approval for its Bangalore manufacturing units
These facilities are used for the manufacture of DS and DP for Biosimilars: Bevacizumab, Trastuzumab, Pegfilgrastim and secondary packaging of Insulin Glargine for EU markets, and were inspected in March 2020.
View: How to test Covid-19 rationally
Datta is chief scientific officer, Bugworks Research, Bengaluru, and Ghosh is professor of mathematics, Indian Institute of Science Bangalore
